跳至主要内容
临床试验/NCT04260659
NCT04260659已完成4 期

Opioid Free vs Opioid Based Anesthesia for Laparoscopic Sleeve Gastrectomy: Clinical, Randomised Study

Medical University of Warsaw1 个研究点 分布在 1 个国家目标入组 59 人开始时间: 2020年2月4日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
59
试验地点
1
主要终点
Postoperative pain score in NRS scale

研究概览

简要总结

Opioid free anesthesia is an anesthetic technique, in which administration of multimodal analgesia and sympathicolytics provides hemodynamic stability without use of opioids. Such management may be beneficial to the obese patients undergoing laparoscopic sleeve gastrectomy. Our study aims to compare opioid free anesthesia in such patients with standard, short-acting opioid based.

详细描述

The study has been approved by Bioethical Committee of Medical University of Warsaw. Informed written consent will be obtained from all patients. Sample size of 60 patients has been calculated based on the Altman normogram to obtain 30% reduction of postoperative opioid consumption with significance and power of 90%.

Consenting patients scheduled for laparoscopic sleeve gastrectomy will be randomly assigned to the computer generated list to receive opioid free or standard opioid based anesthesia.

Opioid free protocol includes administration of dexmedetomidine, lidocaine, ketamine, magnesium sulphate whereas standard group will receive remifentanil TCI Minto Model.

After the end of operation all of the patient will receive oxycodone and additional doses via PCA system for postoperative analgesia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Sleeve gastrectomy in patients with BMI > 40 or >35 with comorbidities
  • Written informed consent

排除标准

  • Patient's refusal
  • Known allergies to study medication
  • Inability to comprehend or participate In pain scoring scale
  • Inability to use intravenous patient controlled analgesia
  • Changes of operation extent during procedure
  • Revisional operations

研究组 & 干预措施

Opioid free group

Experimental

干预措施: Magnesium Sulphate [Inj. Magnesii Sulfurici Polpharma] (Drug)

Opioid liberal group

Active Comparator

干预措施: Remifentanil [Ultiva] (Drug)

Opioid free group

Experimental

干预措施: Dexmedetomidine Hydrochloride [Dexdor] (Drug)

Opioid free group

Experimental

干预措施: Ketamine [Ketalar] (Drug)

Opioid free group

Experimental

干预措施: Lidocaine [Xylocaine 2%] (Drug)

Opioid free group

Experimental

干预措施: Fentanyl [Fentanyl WZF] (Drug)

结局指标

主要结局

Postoperative pain score in NRS scale

时间窗: Day "1" assessed 24 hours after operation

NRS range from 0 for no pain to 10 for worst pain imaginable

Total postoperative oxycodone consumption

时间窗: Day "0"

PCA (Patient's controlled analgesia) iv pump, oxycodone will be administered on patient's demand by 2mg boli, with lock out time 10 minutes

次要结局

  • Total ephedrine dosis(intraoperative)
  • Postoperative desaturation(Day "0", assessed 1,6,12 and 24 hours after operation)
  • Patient's comfort assessed in QoR-40 formulary(7 days postoperatively)
  • Postoperative nausea and vomiting(Day "0", assessed 1,6,12 and 24 hours after operation)
  • Rescue fentanyl administration dosis(intraoperative)
  • Highest BP(intraoperative)
  • Lowest BP(intraoperative)
  • Highest HR(intraoperative)
  • Lowest HR(intraoperative)
  • Postoperative sedation score(Day "0", assessed 1,6,12 and 24 hours after operation)

研究者

发起方
Medical University of Warsaw
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验